Stocks
Moderna Financial Statements (MRNA) |
||||||||||
| Modernasmart-lab.ru | % | 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 26.02.2021 | 25.02.2022 | 31.12.2022 | 24.02.2023 | 23.02.2024 | 02.05.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 274.5 | 17 736 | 19 263 | 19 263 | 6 754 | 6 642 | |||
| Operating Income, bln rub | -763.1 | 13 296 | 9 420 | 9 420 | -4 239 | -5 284 | ||||
| EBITDA, bln rub | ? | -763.1 | 13 296 | 9 923 | 9 768 | -3 211 | -4 705 | |||
| Net profit, bln rub | ? | -747.1 | 12 202 | 8 362 | 8 362 | -4 714 | -8 218 | |||
| OCF, bln rub | ? | 2 027 | 13 620 | 4 981 | 4 981 | -3 118 | -1 967 | |||
| CAPEX, bln rub | ? | 67.4 | 284.0 | 400.0 | 400.0 | 707.0 | 556.0 | |||
| FCF, bln rub | ? | 1 960 | 13 336 | 4 581 | 4 581 | -3 825 | -2 523 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 1 030 | 1 823 | 4 427 | 4 427 | 6 300 | 6 383 | ||||
| Cost of production, bln rub | 7.93 | 2 617 | 5 416 | 5 416 | 4 693 | 5 543 | ||||
| R&D, bln rub | 1 370 | 1 991 | 3 295 | 3 295 | 4 845 | 4 753 | ||||
| Interest expenses, bln rub | 9.89 | 18.0 | 0.000 | 29.0 | 38.0 | 22.0 | ||||
| Assets, bln rub | 7 337 | 24 669 | 25 858 | 25 858 | 18 426 | 16 729 | ||||
| Net Assets, bln rub | ? | 2 561 | 14 145 | 19 123 | 19 123 | 13 854 | 12 817 | |||
| Debt, bln rub | 207.3 | 916.0 | 1 004 | 1 200 | 1 243 | 1 237 | ||||
| Cash, bln rub | 5 246 | 17 570 | 9 902 | 9 902 | 8 604 | 8 540 | ||||
| Net debt, bln rub | -5 039 | -16 654 | -8 898 | -8 702 | -7 361 | -7 303 | ||||
| Ordinary share price, rub | 104.5 | 254.0 | 179.6 | 179.6 | 99.5 | 71.1 | ||||
| Number of ordinary shares, mln | 381.3 | 403.0 | 394.0 | 394.0 | 382.0 | 382.0 | ||||
| Market cap, bln rub | 39 838 | 102 354 | 70 770 | 70 770 | 37 990 | 27 141 | ||||
| EV, bln rub | ? | 34 799 | 85 700 | 61 872 | 62 068 | 30 629 | 19 838 | |||
| Book value, bln rub | 2 561 | 14 145 | 19 123 | 19 123 | 13 758 | 12 722 | ||||
| EPS, rub | ? | -1.96 | 30.3 | 21.2 | 21.2 | -12.3 | -21.5 | |||
| FCF/share, rub | 5.14 | 33.1 | 11.6 | 11.6 | -10.0 | -6.60 | ||||
| BV/share, rub | 6.72 | 35.1 | 48.5 | 48.5 | 36.0 | 33.3 | ||||
| EBITDA margin, % | ? | -278.0% | 75.0% | 51.5% | 50.7% | -47.5% | -70.8% | |||
| Net margin, % | ? | -272.2% | 68.8% | 43.4% | 43.4% | -69.8% | -123.7% | |||
| FCF yield, % | ? | 4.92% | 13.0% | 6.47% | 6.47% | -10.1% | -9.30% | |||
| ROE, % | ? | -29.2% | 86.3% | 43.7% | 43.7% | -34.0% | -64.1% | |||
| ROA, % | ? | -10.2% | 49.5% | 32.3% | 32.3% | -25.6% | -49.1% | |||
| P/E | ? | -53.3 | 8.39 | 8.46 | 8.46 | -8.06 | -3.30 | |||
| P/FCF | 20.3 | 7.68 | 15.4 | 15.4 | -9.93 | -10.8 | ||||
| P/S | ? | 145.1 | 5.77 | 3.67 | 3.67 | 5.62 | 4.09 | |||
| P/BV | ? | 15.6 | 7.24 | 3.70 | 3.70 | 2.76 | 2.13 | |||
| EV/EBITDA | ? | -45.6 | 6.45 | 6.24 | 6.35 | -9.54 | -4.22 | |||
| Debt/EBITDA | 6.60 | -1.25 | -0.90 | -0.89 | 2.29 | 1.55 | ||||
| R&D/CAPEX, % | 2 032% | 701.1% | 823.8% | 823.8% | 685.3% | 854.9% | ||||
| CAPEX/Revenue, % | 24.6% | 1.60% | 2.08% | 2.08% | 10.5% | 8.37% | ||||
| Moderna shareholders | ||||||||||
